A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
RasCal Therapeutics, Inc.
Conjupro Biotherapeutics, Inc.
IRCCS Azienda Ospedaliero-Universitaria di Bologna
AbbVie
Eisai Inc.
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
AbbVie
Revolution Medicines, Inc.
Alterome Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
UMC Utrecht
Pfizer
University of Aarhus
Nuvectis Pharma, Inc.
Palo Alto Veterans Institute for Research
ViroMissile, Inc.
Amgen
Sichuan Enray Pharmaceutical Sciences Company
Astellas Pharma Inc
AstraZeneca
A2 Biotherapeutics Inc.
University of Florida
VA Office of Research and Development
Amgen
Tizona Therapeutics, Inc
Essen Biotech
Essen Biotech
National Institutes of Health Clinical Center (CC)
A2 Biotherapeutics Inc.
Tempus AI
Icahn School of Medicine at Mount Sinai
Iambic Therapeutics, Inc
Pheon Therapeutics
DualityBio Inc.
EXoPERT
Elephas
Dysplasia Diagnostics Limited
Var2 Pharmaceuticals
Elephas
Calico Life Sciences LLC
GlaxoSmithKline
Sairopa B.V.
GV20 Therapeutics
Rutgers, The State University of New Jersey
Cancer Research UK
Krystal Biotech, Inc.
Rondo Therapeutics
Weill Medical College of Cornell University
UNC Lineberger Comprehensive Cancer Center